Gary Herbert Lyman

Gary Herbert Lyman
Born
United States
NationalityAmerican
Occupation(s)Hematologist, medical oncologist, academic and author
Academic background
EducationBachelor of Arts
Doctor of Medicine
Master of Public Health
Alma materState University of New York at Buffalo
Harvard University School of Public Health
Academic work
InstitutionsFred Hutchinson Cancer Center
Duke University

Gary Herbert Lyman is an American academic hematologist, medical oncologist, and cancer researcher.[1]

Lyman is most known for his efforts in managing the adverse effects of cancer treatment including neutropenia and thrombosis among other toxicities along with establishing the clinical application of colony-stimulating factors and oral anticoagulants. He has also led efforts to address rising health care costs through national policy initiatives, clinical practice guidelines and the clinical integration of biosimilars and other approaches to reducing the financial burden of cancer on patients. His contributions extend to the development and validation of risk prediction models and the application of biomarkers for molecularly targeted therapies. Among his authored works are his publications in academic journals[2] as well as books such as Comprehensive geriatric oncology,[3] Breast cancer : Translational Therapeutic Strategies,[4] Cancer Supportive Care: Advances in Therapeutic Strategies,[5] and Hematopoietic Growth Factors in Oncology.[6] He is a Distinguished Emeritus member of the American Society of Hematology as well as the recipient of the Statesman Award from the American Society of Clinical Oncology.[7]

  1. ^ "Gary Herbert Lyman | Duke Department of Medicine". medicine.duke.edu. Archived from the original on 2024-04-22. Retrieved 2024-04-22.
  2. ^ "Gary Lyman". scholar.google.com. Archived from the original on 2024-04-22. Retrieved 2024-04-22.
  3. ^ Balducci, Lodovico; Lyman, Gary H.; Ershler, William B.; Balducci, Lodovico; Ershler, William B.; Lyman, Gary H.; Extermann, Martine, eds. (2004). Comprehensive Geriatric Oncology. doi:10.3109/9780203494516. ISBN 978-0-429-26169-5.[non-primary source needed][page needed]
  4. ^ "Breast cancer: Translational Therapeutic Strategies". Archived from the original on 2024-04-22. Retrieved 2024-04-22.
  5. ^ "Cancer supportive care : advances in therapeutic strategies". Archived from the original on 2024-04-22. Retrieved 2024-04-22.
  6. ^ "Hematopoietic Growth Factors in Oncology". Archived from the original on 2024-04-22. Retrieved 2024-04-22.
  7. ^ "Special recognitions: April–Sept 2010". Duke Department of Medicine. October 18, 2010. Archived from the original on April 22, 2024. Retrieved April 22, 2024.